04:52 PM EST, 11/08/2024 (MT Newswires) -- Mich J Mathews-Spradlin, Director, on November 07, 2024, sold 24,462 shares in Wendy's (WEN) for $496,089. Following the Form 4 filing with the SEC, Mathews-Spradlin has control over a total of 63,789 shares of the company, with 63,789 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/30697/000112760224026851/xslF345X05/form4.xml Price: 19.82, Change: -0.07, Percent Change: -0.35 ...

04:51 PM EST, 11/08/2024 (MT Newswires) -- Tredegar ( TG ) reported a Q3 loss late Friday of $0.11 per diluted share, narrower than a loss of $1.47 per share a year earlier. Analyst estimates weren't available. Sales for the quarter ended Sept. 30 were $182.1 million, up from $166.2 million a year earlier. ...

04:51 PM EST, 11/08/2024 (MT Newswires) -- Robert Buckley, Chief Financial Officer, on November 06, 2024, sold 3,660 shares in Novanta ( NOVT ) for $660,184. Following the Form 4 filing with the SEC, Buckley has control over a total of 120,419 shares of the company, with 120,419 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1076930/000112760224026852/xslF345X05/form4.xml ...

04:53 PM EST, 11/08/2024 (MT Newswires) -- Fate Therapeutics ( FATE ) said late Friday that preclinical data for its CAR T-cell candidate FT836 demonstrated the product's potential for durable anti-tumor activity without intervention. The data support the pan-cancer activity of MICA/B targeting, and indicate that our next-generation, iPSC-derived CAR T-cell platform has the potential to drive potent and durable...